2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $17B | $30B | $49B | $53B | $54B |
Cost of Revenue | $25B | $30B | $40B | $41B | $38B |
Gross Profit | -$7.6B | $27M | $9B | $12B | $17B |
Gross Profit % | -44% | 0.09% | 18% | 22% | 31% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$8.9B | -$2B | $127M | $822M | $846M |
Dep. & Amort. | $2.4B | $2.3B | $2.3B | $2.3B | $2.2B |
Def. Tax | -$2.6B | -$555M | $65M | $299M | $0 |
Stock Comp. | $91M | $98M | $78M | $102M | $89M |
Chg. in WC | $1.2B | $1B | -$637M | $236M | $815M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $245M | $273M | $440M | $578M | $804M |
ST Investments | $6.6B | $13B | $9.4B | $7.8B | $6.2B |
Cash & ST Inv. | $6.9B | $13B | $9.8B | $7.6B | $7B |
Receivables | $1.3B | $1.5B | $2.1B | $2B | $2B |
Inventory | $1.6B | $1.8B | $2.3B | $2.4B | $2.6B |
American Airlines reported a Q1 2025 GAAP net loss of $473M and an adjusted net loss of $386M ($0.59 per diluted share), with revenue of $12.6B (down 0.2% YoY) and unit revenue up 0.7% YoY.
The company is withdrawing its full-year outlook due to economic uncertainty and pressured demand, but expects to deliver a profitable year and positive free cash flow if current demand trends continue; Q2 earnings are forecasted at $0.50 to $1.00 per diluted share.
International and premium segments are outperforming, with Atlantic passenger RASM up 10.5% YoY, Pacific up 4.9%, and premium revenue up 3% YoY; domestic main cabin demand is weak, with mid to high single-digit RASM declines expected in that segment for the summer.
Cost management remains a focus: $250M in cost savings expected in 2025 (on top of $500M in 2024), working capital improvements, and mainline FTE count to remain flat; aircraft CapEx for 2025 is expected at $2B–$2.5B, with total CapEx at $3B–$3.5B.
Balance sheet has strengthened with net debt at its lowest since 2015, $10.8B in liquidity, and a commitment to reduce total debt below $35B by year-end 2027; capacity growth for Q2 is guided at 2–4% YoY, with a negative bias to further capacity increases for the rest of the year due to ongoing demand uncertainty.